Patent Application for Variable Orifice Flow Shunt Devices
Summary
The USPTO has published a patent application (US20260083945A1) for variable orifice flow shunt devices designed to reduce peak systolic pressure. The application details devices with check valves and adjustable orifices for percutaneous shunting from the superior vena cava to the right pulmonary artery.
What changed
This document is a published patent application from the USPTO detailing a novel shunt device. The application, titled 'VARIABLE ORIFICE FLOW', describes devices configured for percutaneous shunting from the superior vena cava to the right pulmonary artery, featuring a check valve with a specific cracking pressure and a physiologically responsive adjustable orifice. The technology aims to reduce peak systolic pressure and includes flow control systems with variable orifice constrictors.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future product development and innovation in the medical device sector, particularly for cardiovascular treatments. Companies in this space should be aware of this technological development as it may influence future product pipelines and competitive landscapes.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
VARIABLE ORIFICE FLOW
Application US20260083945A1 Kind: A1 Mar 26, 2026
Inventors
Hengchu Cao, Ming H. Wu, Ralph Schneider, Maximilien Evans Launey
Abstract
Described herein are shunt devices configured to achieve a targeted reduction in peak systolic pressure by percutaneously shunting from the superior vena cava to the right pulmonary artery. The shunt devices include a check valve with a cracking pressure to preserve a minimal transpulmonary pressure. Also described herein are flow diversion devices placed between pulmonary circulation vessels and venous vessels. The disclosed flow diversion devices are physiologically responsive through an adjustable orifice that can be adjusted after initial implantation through a non-invasive or minimally invasive procedure. Disclosed herein are flow control systems that are configured to reduce recruitment of blood from the splanchnic system. The flow control systems include a variable orifice constrictor (e.g., a covered stent) and a controller that delivers energy to the constrictor to reduce the cross-sectional area of the lumen through the variable orifice constrictor.
CPC Classifications
A61M 27/002 A61F 2/2476 A61F 2/482 A61F 2220/0016 A61F 2230/001 A61F 2230/0069 A61F 2250/0007 A61F 2250/001 A61F 2250/0039 A61M 2039/242 A61M 2205/0266 A61M 2205/0272 A61M 2205/04 A61M 2205/3327 A61M 2205/3344 A61M 2205/50 A61M 2210/12 A61M 2230/005 A61M 2230/30
Filing Date
2025-11-25
Application No.
19400924
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.